Eupraxia Pharmaceuticals Inc., a clinical stage biotechnology company, engages in the discovery, development, and marketing of technologies in the biotechnology sector. The company's lead product candidates are EP-104IAR, which is in a Phas...
Q1 2026
May 5, 2026
FY 2025
Mar 12, 2026
Q4 2025
Q2 2025
Aug 12, 2025
Q1 2025
May 6, 2025